CSM Corbion NV

Corbion: Full Year 2022 Results

Corbion: Full Year 2022 Results

Corbion, the Amsterdam-listed company that champions preservation through the application of science, today publishes its annual results for the year ending 31 December 2022.

2022 Key highlights include:

  • Total net sales growth of 36.2% at €1,457.9 million (FY 2021: €1,070.8 million)
  • Organic net sales growth of 24.6%. Core organic net sales growth: 24.3%.
  • Adjusted EBITDA was €184.4 million (FY 2021: €135.8 million; organic increase: 17.9%)
  • Operating result was €110.8 million (FY 2021: €82.0 million)
  • Free cash flow was €-160.1 million (FY 2021: €-97.0 million)
  • Covenant net debt/covenant EBITDA reduced to 3.0x (H1 2022: 3.3x)
  • Proposed regular cash dividend of €0.56 per share
  • Advance 2025 strategy implementation and updated objectives remain on track
  • Near-term guidance and medium targets are unchanged





€ millionYTD 2022YTD 2021Total growthOrganic growth
Net sales1,457.91,070.836.2%24.6%
Adjusted EBITDA184.4135.835.8%17.9%
Adjusted EBITDA margin12.6%12.7%  
Operating result110.882.035.1%18.1%
ROCE9.6%9.6%  

Commenting on today’s results, Olivier Rigaud, CEO, said:

“We are proud to have delivered strong growth in both sales and EBITDA during a period of unprecedented cost inflation and supply chain disruptions. Our full-year organic sales growth of 24.6% and organic Adjusted EBITDA growth of 17.9% demonstrate the strong potential of our strategy and excellence of execution. We successfully increased prices to compensate for additional input costs and delivered a volume/mix growth in the core business of 5.6%, despite the previously highlighted slowdown in the PLA market. Algae Ingredients continued its strong growth dynamics. We have made substantial progress in our sustainability efforts during 2022 and by the end of the year our more ambitious emission reduction targets have been validated by the Science Based Target Initiative (SBTi). The new reduction goals align with the ambition to limit average global temperature rise to 1.5°C. Our strategy to drive sustainable growth is showing results, and we are confident achieving our updated Advance 2025 initiatives and targets.”

Attachment



EN
03/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corbion NV

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Livio Luyten
  • Lynn Hautekeete
  • Mathijs Geerts Danau
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List How to start 2026?

How to start 2026? We have selected for the KBC Securities Dynamic Top Pick List 12 large-cap companies — AB InBev, Aedifica, Argenx, ASMi, Azelis, DEME, D'Ieteren, Shurgard, Sofina, Vopak, WDP, and Wolters Kluwer — along with 3 small and mid-cap names (under €1.5bn in market capitalization): Corbion, EVS, and IBA. So, going into 2026, we maintain a balanced approach in our Dynamic Top Pick List, featuring 8 cyclical and 6 defensive stocks, with a particular emphasis on value stocks that have b...

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Livio Luyten
  • Thomas Couvreur
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Corbion Strategy update shows increased focus, upgrade to BUY

Corbion's BRIGHT 2030 strategy update revealed an increasing focus on clean label Food Ingredients, Nutrition and Biomedical Polymers/Pharma. Biochemicals are being de-prioritized and the strategic ownership review on PLA will most likely result in an exit. Financial targets include a 3-6% annual organic sales growth target and a c 2pp increase in the adjusted EBITDA margin by 2028. A disciplined approach on capex is expected to result in an average 8% FCF yield in the coming years with a streng...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch